EUR HEART J 润色咨询

EUROPEAN HEART JOURNAL

出版年份：1980 年文章数：2235 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：6.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2016-01-19 VivianGGG

    To: vvsquare
    请问如何知道是否送外审呢？
    我投稿之后先是大概3天的managing editor - submitted to journal。
    之后一直是under reviewer到现在大概10天。并没有中间其他状态。。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2022-03-22 ms5000000159743145

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向：冠脉粥样硬化;降脂;超声
    经验分享：暂无

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2020-04-22 swimmingly

    审稿速度:1.0
    经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2021-12-27 MS68862005

    两个IF相当的期刊，如何选择要投哪个？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    选刊时有什么原则吗？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2017-10-26 1204b345m76(暂无昵称)

    收case?hukuisuda 2015-11-17 发表::
    研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.

    hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2019-06-21 lovetcm

    与circulation并驾齐驱，超过JACC不少了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2019-05-25 聪酱

    请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表:
    明年可能会过20分！与JACC，circulation并架齐驱，是三架马车

    lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2019-04-16 1210f463m66(暂无昵称)

    文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=518558, encodeId=069b5185587d, content=To: vvsquare <br> 请问如何知道是否送外审呢？ <br> 我投稿之后先是大概3天的managing editor - submitted to journal。 <br> 之后一直是under reviewer到现在大概10天。并没有中间其他状态。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1660, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78481629572, createdName=VivianGGG, createdTime=Tue Jan 19 09:14:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：冠脉粥样硬化;降脂;超声<br>经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4048, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589437, encodeId=351e58943e8d, content=审稿速度:1.0<br>经验分享：先心病相关的，两个reviewer,一审18天，都给了中肯的意见，编辑部给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5049, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6AF6B21D69F3602EF6483F1668ACA992/100, createdBy=93c42216575, createdName=swimmingly, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3813, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4666, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548622, encodeId=94165486227e, content=收case?<span class="quote">hukuisuda 2015-11-17 发表::<br>研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了.</span>, beContent=hukuisuda 2015-11-17 发表:: 研究方向:心血管;; 接收率:约5% 审稿时间:约1个月 SCI(2014):15.023投了一篇case.两周就拒了.一个reviewer说了一个字:congratulation.另一个说了很多.批得一文不值.editor直接拒了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=5389, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 17:21:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2833, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢<span class="quote">lovetcm 2017-10-15 12:38:00 发表:<br>明年可能会过20分！与JACC，circulation并架齐驱，是三架马车</span>, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3729, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2766, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548248, encodeId=e75c5482488d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Oct 15 12:38:00 CST 2017, time=2017-10-15, status=1, ipAttribution=)]
    2017-10-15 lovetcm

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：明年可能会过20分！与JACC，circulation并架齐驱，是三架马车

    0

共71条页码: 2/8页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分